Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

Go back to Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
(NASDAQ: KROS) Delayed: 11.03 -0.2 (1.78%)
Previous Close $11.23    52 Week High
Open $11.15    52 Week Low
Day High $11.16    P/E N/A 
Day Low $10.58    EPS
Volume 328,289